StatisticaMedica Ltd is a leading biostatistical and high-level strategic consulting clinical research organisation committed to guiding you throughout the drug and medical device development process.

We specialise in the design, data analysis and reporting of clinical trials in the global pharmaceutical, medical device and healthcare industries, and academia. Founded in Dublin, Ireland in 2012 and with teams in Ireland, Italy and the UK, StatisticaMedica provides first-class biostatistical support, underpinned by our core values of integrity, consistency and exceptional quality.

Under the pioneering direction of founder and CEO, Gloria Crispino PhD, our experienced team of biostatisticians combined with our specialist medical writing consultancy offer a unique blend of skills and expertise for the successful execution of your clinical development programme.

With our first-rate knowledge and understanding of advanced biostatistics, study design, biostatistical analyses, regulatory statistics, and medical writing, we provide comprehensive, high quality support from preclinical research analyses through to biostatistical analyses and reporting of large Phase III clinical trials in a variety of therapeutic areas.

We deliver to the highest regulatory grade for the quality of our biostatistics deliverables, with a 97-100% Pinnacle data fitness score for all regulatory FDA submissions.